Literature DB >> 29611176

The epidemiology of rasburicase use in paediatric patients with acute lymphoblastic leukaemia and non-Hodgkin lymphoma.

Rebecca Citrin1, Kelly D Getz1,2, Yimei Li1,3,4, Yuan-Shung Huang2, Joseph P Horowitz5, Alix E Seif1,4, Brian T Fisher3,2,4,6, Richard Aplenc1,3,2,4.   

Abstract

Entities:  

Keywords:  hyperuricaemia; non-Hodgkin lymphoma, acute leukaemia; rasburicase; tumour lysis syndrome.

Mesh：

Substances：

Year:  2018        PMID： 29611176      PMCID： PMC6168433          DOI： 10.1111/bjh.15159

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  9 in total

Review 1.  Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus.

Authors:  Mitchell S Cairo; Bertrand Coiffier; Alfred Reiter; Anas Younes
Journal:  Br J Haematol       Date:  2010-03-16       Impact factor: 6.998

2.  Management of tumour lysis syndrome in children: what is the evidence for prophylactic rasburicase in non-hyperleucocytic leukaemia?

Authors:  Anurag K Agrawal; James H Feusner
Journal:  Br J Haematol       Date:  2011-01-23       Impact factor: 6.998

Review 3.  The tumor lysis syndrome.

Authors:  Scott C Howard; Deborah P Jones; Ching-Hon Pui
Journal:  N Engl J Med       Date:  2011-05-12       Impact factor: 91.245

4.  Variation in hospital antibiotic prescribing practices for children with acute lymphoblastic leukemia.

Authors:  Brian T Fisher; Jeffrey S Gerber; Kateri H Leckerman; Alix E Seif; Yuan-Shung V Huang; Yimei Li; Tracey Harris; Kari Torp; Rheam Douglas; Ami Shah; Dana Walker; Richard Aplenc
Journal:  Leuk Lymphoma       Date:  2012-12-26

5.  Establishment of an 11-year cohort of 8733 pediatric patients hospitalized at United States free-standing children's hospitals with de novo acute lymphoblastic leukemia from health care administrative data.

Authors:  Brian T Fisher; Tracey Harris; Kari Torp; Alix E Seif; Ami Shah; Yuan-Shung V Huang; L Charles Bailey; Leslie S Kersun; Anne F Reilly; Susan R Rheingold; Dana Walker; Yimei Li; Richard Aplenc
Journal:  Med Care       Date:  2014-01       Impact factor: 2.983

6.  Outcome of pediatric acute myeloid leukemia patients receiving intensive care in the United States.

Authors:  Shannon L Maude; Julie C Fitzgerald; Brian T Fisher; Yimei Li; Yuan-Shung Huang; Kari Torp; Alix E Seif; Marko Kavcic; Dana M Walker; Kateri H Leckerman; Todd J Kilbaugh; Susan R Rheingold; Lillian Sung; Theoklis E Zaoutis; Robert A Berg; Vinay M Nadkarni; Neal J Thomas; Richard Aplenc
Journal:  Pediatr Crit Care Med       Date:  2014-02       Impact factor: 3.624

7.  SFCE (Société Française de Lutte contre les Cancers et Leucémies de l'Enfant et de l'Adolescent) recommendations for the management of tumor lysis syndrome (TLS) with rasburicase: an observational survey.

Authors:  Yves Bertrand; Françoise Mechinaud; Benoit Brethon; Valerie Mialou; Anne Auvrignon; Brigitte Nelken; Anne Notz-Carrère; Dominique Plantaz; Catherine Patte; Marisol Urbieta; André Baruchel; Guy Leverger
Journal:  J Pediatr Hematol Oncol       Date:  2008-04       Impact factor: 1.289

8.  Dexrazoxane use in pediatric patients with acute lymphoblastic or myeloid leukemia from 1999 and 2009: analysis of a national cohort of patients in the Pediatric Health Information Systems database.

Authors:  Dana M Walker; Brian T Fisher; Alix E Seif; Yuan-Shung V Huang; Kari Torp; Yimei Li; Richard Aplenc
Journal:  Pediatr Blood Cancer       Date:  2012-09-04       Impact factor: 3.167

9.  Creation of a pediatric mature B-cell non-Hodgkin lymphoma cohort within the Pediatric Health Information System Database.

Authors:  Rebecca Citrin; Joseph P Horowitz; Anne F Reilly; Yimei Li; Yuan-Shung Huang; Kelly D Getz; Alix E Seif; Brian T Fisher; Richard Aplenc
Journal:  PLoS One       Date:  2017-10-23       Impact factor: 3.240
  9 in total
  1 in total

1.  Evaluation of the safety and efficacy of low-dose rasburicase in critically ill children with haematological malignancies.

Authors:  Yuxin Pei; Yu Li; Yujian Liang; Lingling Xu; Xueqiong Huang; Yijuan Li; Wen Tang; Xiaoyun Jiang
Journal:  Int J Clin Pharm       Date:  2020-09-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.